CA
NZ
UK
AU
IND
US
Omeros (NASDAQ:OMER) closed down 13.57% at $16.24 on Oct. 16, 2026, after the European Medicines Agency's CHMP issued a negative opinion on its marketing authorization application for narsoplimab in hematopoietic stem cell transplant-associated thrombotic microangiopathy, or TA-TMA. The decision followed a re-examination of the …
Picard Medical (NYSE American:PMI) closed up 27.00% at $12.70 on Oct. 16, 2026, after a volatile, headline-driven session. Trading in the stock was halted for volatility on Oct. 15 after a 21% drop, and early moves on Friday swung between a decline of about …
Strata Critical Medical (NASDAQ:SRTA) closed up 4.72% at $4.55 on Oct. 16, 2026, after investor Third Point called on the company to weigh strategic alternatives, including a potential sale. Third Point, which owns a 5.8% stake, changed its regulatory filing from a 13G, used …
● The company announced no results, guidance or deal that day.
● The company reported no earnings, product or other news that day.
● UBS initiated coverage of BioMarin with a Buy rating.
● The company published no results, guidance or other announcement that day.
● No trial result, regulatory decision or earnings drove the move.
● The bank voiced optimism about Moderna’s Phase 3 melanoma results.
● VITAS Healthcare net revenue grew 11.9 per cent, with admissions up 9.0 per cent.
Please wait processing your request...